Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alvarez

Showing results (431-440 of 644) with videos related to

Pageof 65
Sort By:
Molecular Cancer Therapeutics|May 4, 2012
Smoothened antagonists reverse taxane resistance in ovarian cancerAdam D Steg, Ashwini A Katre, Kerri S Bevis, et al.
Gynecologic Oncology|October 19, 2001
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervixW K Huh, J Gomez-Navarro, W O Arafat, et al.
Chest|February 1, 1993
Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gammaL Valdés, E San José, D Alvarez, et al.
Gynecologic Oncology|November 26, 2015
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group studyRodney P Rocconi, Heather A Lankes, William E Brady, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|May 1, 1985
[Spontaneous choledocoduodenostomy caused by lithiasis of hydatid origin in hepatic hydatidosis with massive invasion of the bile ducts]R Gil-Albarellos Marcos, D Alvarez Ruíz de Viñaspre, A Alvarez Ruíz de Viñaspre, et al.
Gynecologic Oncology|December 22, 1999
Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trialsA R Calkins, C R Harrison, W C Fowler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|October 6, 2006
[Guidelines for the diagnosis and management of sleep apnea-hypoapnea syndrome in children]J R Villa Asensi, C Martínez Carrasco, G Pérez Pérez, et al.
Gynecologic Oncology|July 12, 2011
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignanciesAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Pageof 65

Showing results (431-440 of 644) with videos related to

Sort By:
Pageof 65
Molecular Cancer Therapeutics|May 4, 2012
Smoothened antagonists reverse taxane resistance in ovarian cancerAdam D Steg, Ashwini A Katre, Kerri S Bevis, et al.
Gynecologic Oncology|October 19, 2001
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervixW K Huh, J Gomez-Navarro, W O Arafat, et al.
Chest|February 1, 1993
Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gammaL Valdés, E San José, D Alvarez, et al.
Gynecologic Oncology|November 26, 2015
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group studyRodney P Rocconi, Heather A Lankes, William E Brady, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|May 1, 1985
[Spontaneous choledocoduodenostomy caused by lithiasis of hydatid origin in hepatic hydatidosis with massive invasion of the bile ducts]R Gil-Albarellos Marcos, D Alvarez Ruíz de Viñaspre, A Alvarez Ruíz de Viñaspre, et al.
Gynecologic Oncology|December 22, 1999
Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trialsA R Calkins, C R Harrison, W C Fowler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|October 6, 2006
[Guidelines for the diagnosis and management of sleep apnea-hypoapnea syndrome in children]J R Villa Asensi, C Martínez Carrasco, G Pérez Pérez, et al.
Gynecologic Oncology|July 12, 2011
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignanciesAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Pageof 65